Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERCC1 | P07992 | 1/20 | 0.41 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CETP | P11597 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | HTR6 | P50406 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.38 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10051530 | 0.82 | HTR6 (0.38) | MAPK1L3MBTL1MAPTALOX5HTR6 | |
| SCHEMBL627518 | 0.81 | MAPK1 (0.44) | ERCC1ERCC4MAPK1L3MBTL1NPC1 | |
| SCHEMBL799823 | 0.79 | L3MBTL1 (0.42) | MAPK1L3MBTL1NPC1MAPTCETP | |
| SCHEMBL13718066 | 0.73 | NPC1 (0.42) | NPC1KMT2AALDH1A1RAB9A | |
| SCHEMBL13718541 | 0.71 | CYP1A2 (0.50) | MAPK1L3MBTL1NPC1MAPTMEN1 | |
| SCHEMBL4357196 | 0.71 | SLC6A4 (0.36) | MAPK1L3MBTL1NPC1MAPTCETP | |
| SCHEMBL1020371 | 0.70 | NPC1 (0.39) | MAPK1L3MBTL1NPC1MAPTCETP | |
| SCHEMBL1021885 | 0.70 | TAAR1 (0.44) | MAPK1L3MBTL1NPC1MAPTMEN1 | |
| SCHEMBL2002640 | 0.69 | CETP (0.59) | CETPHTR6HTR2CHTR2B | |
| SCHEMBL1219378 | 0.69 | SIRT1 (0.44) | MAPK1L3MBTL1NPC1MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120071663-A1 | Preparation of N'-(4--2,5-dimethylphenyl)-N- ethyl-N-methylimidoformamide | BAYER CROPSCIENCE AG (DE) | 2012-03-22 | — | — | US | disclosed |
| US-20120071663-A1 | Preparation of N'-(4--2,5-dimethylphenyl)-N- ethyl-N-methylimidoformamide | BAYER CROPSCIENCE AG (DE) | 2012-03-22 | — | — | US | disclosed |
| WO-2012019998-A1 | PRODUCTION OF N'-(4-{[3-(4-CHLORBENZYL)-1,2,4-THIADIAZOL-5-YL] OXY} -2,5-DIMETHYLPHENYL)-N-ETHYL-N-METHYLIMIDOFORMAMIDE | BAYER CROPSCIENCE AG (DE) | 2012-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071663-A1 | Preparation of N'-(4--2,5-dimethylphenyl)-N- ethyl-N-methylimidoformamide | NT5C, NT5E, NT5C3B | ERCC1 1879/4885ERCC4 1025/4885MAPK1 3625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.